PTGER4 and urothelial carcinoma: In particular, EP4R has increased expression in human cutaneous squamous cell carcinoma [16], and is the most abundant EP receptor subtype in multiple human malignancies [15] including urinary tract transitional cell carcinoma [17] and colorectal carcinoma [18].